These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20048168)

  • 1. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.
    Kim MS; Yang YM; Son A; Tian YS; Lee SI; Kang SW; Muallem S; Shin DM
    J Biol Chem; 2010 Mar; 285(10):6913-21. PubMed ID: 20048168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.
    Kajiya H; Okamoto F; Nemoto T; Kimachi K; Toh-Goto K; Nakayana S; Okabe K
    Cell Calcium; 2010 Nov; 48(5):260-9. PubMed ID: 20980052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.
    Yang YM; Kim MS; Son A; Hong JH; Kim KH; Seo JT; Lee SI; Shin DM
    J Bone Miner Res; 2009 Oct; 24(10):1763-9. PubMed ID: 19419309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
    Son A; Kang N; Oh SY; Kim KW; Muallem S; Yang YM; Shin DM
    J Endocrinol; 2019 Sep; 242(3):241-249. PubMed ID: 31319381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
    Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.
    Yang S; Li YP
    J Bone Miner Res; 2007 Jan; 22(1):45-54. PubMed ID: 17042716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway.
    Park KH; Park B; Yoon DS; Kwon SH; Shin DM; Lee JW; Lee HG; Shim JH; Park JH; Lee JM
    Cell Commun Signal; 2013 Oct; 11():74. PubMed ID: 24088289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
    Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
    FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
    Hasegawa H; Kido S; Tomomura M; Fujimoto K; Ohi M; Kiyomura M; Kanegae H; Inaba A; Sakagami H; Tomomura A
    J Biol Chem; 2010 Aug; 285(33):25448-57. PubMed ID: 20547767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
    Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K
    Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca
    Zhang J; Xu H; Han Z; Chen P; Yu Q; Lei Y; Li Z; Zhao M; Tian J
    Biochem Biophys Res Commun; 2017 Jan; 482(2):289-295. PubMed ID: 27856256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages.
    Fujimura Y; Hotokezaka H; Ohara N; Naito M; Sakai E; Yoshimura M; Narita Y; Kitaura H; Yoshida N; Nakayama K
    Infect Immun; 2006 May; 74(5):2544-51. PubMed ID: 16622189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation.
    Yang S; Li YP
    Genes Dev; 2007 Jul; 21(14):1803-16. PubMed ID: 17626792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.